| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |